Expanding Accessibility in a Phase 3 Influenza Study Through Community-Based Research: A Collaborative Case Study

This ongoing Phase 3 study seeks to evaluate the safety, efficacy, and immunogenicity
of a new seasonal influenza vaccine compared to a licensed inactivated vaccine
in adults aged 50 and older. Given the potential severity of influenza symptoms and
influenza-related complications, ensuring broad participation and adherence to study
protocols is essential.